Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pidilite Industries Limited (PIDILITIND.NS)
Mumbai, IN
Pidilite Industries Limited, together with its associated companies, specializes in the production and global distribution of both consumer-focused and specialized chemical products. The company's operations are structured around two core business divisions: Branded Consumer & Bazaar, and Business to Business. The Branded Consumer & Bazaar unit provides a diverse portfolio including adhesives, sealants, creative art and craft supplies, and an array of construction and paint-related chemicals, catering to a broad spectrum of users from skilled tradespeople like carpenters, painters, and plumbers, to mechanics, general households, students, and office environments. Conversely, the Business to Business segment delivers specialized products such as industrial-grade adhesives, resins, advanced construction chemicals, organic pigments, and pigment preparations, serving critical needs across diverse industrial sectors, including packaging, woodworking and joinery, textiles, paints and coatings, printing inks, paper manufacturing, and leather processing. Beyond core products, the company extends its expertise to provide solutions in adhesive technologies, wood finishes, protective paints, comprehensive waterproofing services, automotive applications, technical textiles, and tile grouts, encompassing mechanical, electrical, and plumbing (MEP) requirements. Its market presence is significantly marked by an array of well-known brands, including Fevicol, Fevicol MR, Dr. Fixit, Fevikwik, M-Seal, Fevistick, Fevicryl, and Hobby Ideas, among others. Established in 1959, Pidilite maintains its corporate headquarters in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.22% | +0.85% | +7.20% | -2.84% | -1.84% | -1.86% | -5.43% | +12.46% | +54.77% | +380.93% | +46,379.23% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 8 | -1 |
| Buy | 6 | 0 |
| Hold | 2 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth+6.1% Q1'26: +14.1% (vs Q1'25)
-
EPS growth+19.8% Q1'26: +36.9% (vs Q1'25)
-
FCF margin+12.9% Q1'26: +32.0% (vs Q1'25)
-
EBIT margin+20.3% Q1'26: +21.3% (vs Q1'25)
-
ROIC+27.5% Q1'26: +31.7% (vs Q1'25)
-
Share dilution+0.2% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA0.15× Q1'26: 0.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2001 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 19 Rev. Ana. 15 EPS Ana. |
Mar 2027 13 Rev. Ana. 11 EPS Ana. |
Mar 2028 17 Rev. Ana. 15 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.40B
est.
|
26.44B
est: 26.25B (+0.7%)
|
31.27B
est: 31.95B (-2.1%)
|
36.78B
est: 37.18B (-1.1%)
|
42.83B
est: 43.29B (-1.1%)
|
48.44B
est: 49.50B (-2.1%)
|
53.61B
est: 52.90B (+1.3%)
|
56.17B
est: 57.67B (-2.6%)
|
60.78B
est: 61.33B (-0.9%)
|
70.78B
est: 71.42B (-0.9%)
|
72.94B
est: 74.30B (-1.8%)
|
72.93B
est: 70.70B (+3.2%)
|
99.21B
est: 93.15B (+6.5%)
|
117.99B
est: 118.37B (-0.3%)
|
123.83B
est: 125.03B (-1.0%)
|
131.40B
est: 131.74B (-0.3%)
|
145.05B
143.23B – 146.83B
+10.1% YoY
|
161.81B
157.99B – 168.60B
+11.6% YoY
|
179.60B
173.71B – 187.56B
+11.0% YoY
|
195.48B
189.92B – 203.93B
+8.8% YoY
|
| EBITDA |
933.91M
est.
|
4.94B
est: 5.57B (-11.3%)
|
5.22B
est: 5.31B (-1.6%)
|
5.99B
est: 5.63B (+6.4%)
|
6.82B
est: 7.88B (-13.5%)
|
7.72B
est: 8.22B (-6.1%)
|
11.74B
est: 8.59B (+36.7%)
|
12.66B
est: 13.79B (-8.2%)
|
13.40B
est: 15.58B (-14.0%)
|
13.73B
est: 18.40B (-25.4%)
|
15.44B
est: 16.49B (-6.4%)
|
16.49B
est: 14.13B (+16.7%)
|
18.32B
est: 18.43B (-0.6%)
|
19.62B
est: 20.13B (-2.6%)
|
26.47B
est: 40.92B (-35.3%)
|
29.39B
est: 43.50B (-32.4%)
|
47.47B
46.88B – 48.06B
+9.1% YoY
|
52.96B
51.71B – 55.18B
+11.6% YoY
|
58.78B
56.85B – 61.39B
+11.0% YoY
|
63.98B
62.16B – 66.74B
+8.8% YoY
|
| EBIT |
800.13M
est.
|
4.34B
est: 4.77B (-8.9%)
|
4.63B
est: 5.26B (-11.9%)
|
5.33B
est: 5.22B (+2.0%)
|
6.05B
est: 6.59B (-8.2%)
|
6.59B
est: 6.93B (-4.9%)
|
10.78B
est: 6.95B (+55.0%)
|
11.55B
est: 11.62B (-0.6%)
|
12.25B
est: 12.52B (-2.1%)
|
12.52B
est: 14.26B (-12.2%)
|
14.10B
est: 12.86B (+9.7%)
|
14.88B
est: 11.95B (+24.5%)
|
16.39B
est: 15.59B (+5.1%)
|
17.51B
est: 17.03B (+2.8%)
|
23.99B
est: 36.69B (-34.6%)
|
26.72B
est: 38.99B (-31.5%)
|
42.56B
42.03B – 43.08B
+9.1% YoY
|
47.48B
46.36B – 49.47B
+11.6% YoY
|
52.70B
50.97B – 55.03B
+11.0% YoY
|
57.36B
55.73B – 59.84B
+8.8% YoY
|
| Net Income |
543.31M
est.
|
3.08B
est: 3.24B (-4.8%)
|
3.23B
est: 3.77B (-14.5%)
|
4.24B
est: 3.78B (+12.3%)
|
4.50B
est: 4.94B (-8.9%)
|
5.13B
est: 5.25B (-2.4%)
|
8.03B
est: 5.44B (+47.7%)
|
8.60B
est: 8.63B (-0.4%)
|
9.62B
est: 9.30B (+3.5%)
|
9.25B
est: 11.18B (-17.3%)
|
11.16B
est: 9.67B (+15.5%)
|
11.31B
est: 9.84B (+15.0%)
|
12.08B
est: 12.83B (-5.9%)
|
12.73B
est: 13.88B (-8.3%)
|
17.29B
est: 37.02B (-53.3%)
|
20.76B
est: 21.82B (-4.8%)
|
24.49B
23.31B – 25.25B
+12.2% YoY
|
26.81B
25.74B – 27.20B
+9.5% YoY
|
30.31B
26.93B – 32.90B
+13.0% YoY
|
32.13B
31.82B – 34.90B
+6.0% YoY
|
| SGA |
668.13M
est.
|
4.74B
est: 3.99B (+18.9%)
|
2.70B
est: 4.71B (-42.7%)
|
6.76B
est: 5.05B (+33.8%)
|
8.07B
est: 6.08B (+32.7%)
|
7.22B
est: 12.57B (-42.6%)
|
8.05B
est: 12.86B (-37.4%)
|
8.82B
est: 14.51B (-39.2%)
|
9.69B
est: 15.68B (-38.2%)
|
11.16B
est: 18.25B (-38.9%)
|
12.32B
est: 19.02B (-35.2%)
|
11.62B
est: 17.56B (-33.8%)
|
13.33B
est: 22.90B (-41.8%)
|
15.62B
est: 25.01B (-37.5%)
|
19.75B
est: 19.53B (+1.1%)
|
22.87B
est: 20.76B (+10.1%)
|
22.66B
22.38B – 22.94B
+9.1% YoY
|
25.28B
24.68B – 26.34B
+11.6% YoY
|
28.06B
27.14B – 29.30B
+11.0% YoY
|
30.54B
29.67B – 31.86B
+8.8% YoY
|
| EPS |
1.14
est.
|
3.07
est: 6.59 (-53.5%)
|
3.20
est: 6.66 (-52.0%)
|
8.32
est: 8.12 (+2.5%)
|
8.77
est: 9.80 (-10.5%)
|
5.00
est: 10.49 (-52.4%)
|
7.83
est: 7.24 (+8.2%)
|
8.39
est: 8.38 (+0.1%)
|
9.47
est: 9.11 (+3.9%)
|
9.11
est: 9.41 (-3.2%)
|
10.99
est: 12.08 (-9.0%)
|
11.13
est: 11.48 (-3.0%)
|
11.88
est: 12.81 (-7.3%)
|
12.52
est: 13.87 (-9.7%)
|
17.00
est: 35.95 (-52.7%)
|
20.41
est: 20.99 (-2.8%)
|
23.86
22.85 – 24.76
+13.7% YoY
|
25.98
25.24 – 26.66
+8.9% YoY
|
29.55
26.40 – 32.26
+13.7% YoY
|
32.40
31.20 – 34.22
+9.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-10 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sudhanshu Vats | MD & Director | 105M | male |
| Apurva Narendrakumar Parekh | Executive Vice Chairman | 100M | male |
| Kavinder Singh | Joint MD & Executive Director | 92M | male |
| Sandeep Batra | Executive Director of Finance, Chief Financial Officer & Director | 49M | male |
| Madhukar Balvantray Parekh | Executive Chairman of the Board | 40M | male |
| Yogesh Anand | Chief Business Officer of International Operations | — | male |
| Sandeep Tanwani | Chief Marketing Officer | — | male |
| Sanjay Bahadur | Chief Growth Officer of CC Businesses | — | male |
| Saswata Dhar | President Legal | — | male |
| Vivek Sharma | Chief Information & Digital Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PIDILITIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
